<PAGE>
HEALTHAXIS INC. EXHIBIT 11
COMPUTATION OF EARNINGS (LOSS) PER SHARE
<TABLE>
<CAPTION>
(In thousands except per share data) Three Months Ended September 30, Nine Months Ended September 30,
2000 1999 2000 1999
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Primary Earnings (Loss) Per Share
NET INCOME (LOSS) APPLICABLE TO COMMON STOCK: ($6,929) ($23,096) $ (31,990) $ (36,536)
------------------------------------------------------------------------------------------------------------------------------------
WEIGHTED AVERAGE SHARES:
Common stock 13,098 12,462 13,079 12,021
Common stock equivalents applicable to stock
options and warrants * *
------------------------------------------------------------------------------------------------------------------------------------
Total 13,098 12,462 13,079 12,021
------------------------------------------------------------------------------------------------------------------------------------
PRIMARY EARNINGS (LOSS) PER SHARE: (0.53) $ (1.85) $ (2.45) $ (3.04)
------------------------------------------------------------------------------------------------------------------------------------
Fully Diluted Earnings (Loss) Per Share
NET INCOME (LOSS) APPLICABLE TO COMMON STOCK: (6,929) $(23,096) $ (31,990) $ (36,536)
------------------------------------------------------------------------------------------------------------------------------------
WEIGHTED AVERAGE SHARES:
Common stock 13,098 12,462 13,079 12,021
Common stock equivalents applicable to stock
options and warrants * * * *
------------------------------------------------------------------------------------------------------------------------------------
Total 13,098 12,462 13,079 12,021
------------------------------------------------------------------------------------------------------------------------------------
FULLY DILUTED EARNINGS (LOSS) PER SHARE: (0.53) $ (1.85) $ (2.45) $ (3.04)
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
* Anti-dilutive; therefore effects have been excluded.
